Geron Corporation
Clinical trials sponsored by Geron Corporation, explained in plain language.
-
New drug could free MDS patients from constant blood transfusions
Disease control OngoingThis study tests a drug called imetelstat in people with a bone marrow disorder (MDS) who currently need regular blood transfusions. The goal is to see if the drug can help them go without transfusions for at least 8 weeks. About 289 adults with low- or intermediate-risk MDS that…
Phase: PHASE2, PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New hope for hard-to-treat bone marrow cancer: experimental drug aims to extend life
Disease control OngoingThis study tests an experimental drug called imetelstat against the best available treatments for people with a rare bone marrow cancer called myelofibrosis. Participants have an advanced form of the disease that no longer responds to standard therapy. The main goal is to see if …
Phase: PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated May 19, 2026 12:01 UTC